Viking Therapeutics
VKTX
VKTX
422 hedge funds and large institutions have $2.53B invested in Viking Therapeutics in 2025 Q4 according to their latest regulatory filings, with 108 funds opening new positions, 115 increasing their positions, 134 reducing their positions, and 44 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
14% more funds holding
Funds holding: 370 → 422 (+52)
0.26% more ownership
Funds ownership: 63.38% → 63.64% (+0.26%)
14% less repeat investments, than reductions
Existing positions increased: 115 | Existing positions reduced: 134
Holders
422
Holding in Top 10
5
Calls
$366M
Puts
$139M
Top Buyers
| 1 | +$55.2M | |
| 2 | +$36M | |
| 3 | +$29.6M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$27.2M |
| 5 |
Jane Street
New York
|
+$25.1M |
Top Sellers
| 1 | -$71.9M | |
| 2 | -$26.7M | |
| 3 | -$23.9M | |
| 4 |
Morgan Stanley
New York
|
-$23.1M |
| 5 |
B
Braidwell
Stamford,
Connecticut
|
-$20M |
